{ "@type": "Dataset", "name": "@evidpediatria on X", "description": "Followers, posts and engagement for @evidpediatria.", "url": "https://tweetindex.com/account/evidpediatria", "isAccessibleForFree": true, "creator": { "@id": "https://tweetindex.com/#organization" }, "variableMeasured": [ { "@type": "PropertyValue", "name": "Followers", "value": 24677 }, { "@type": "PropertyValue", "name": "Following", "value": 4599 }, { "@type": "PropertyValue", "name": "Posts", "value": 40748 }, { "@type": "PropertyValue", "name": "Collected posts", "value": 5 }, { "@type": "PropertyValue", "name": "Views on collected posts", "value": 3502 }, { "@type": "PropertyValue", "name": "Likes on collected posts", "value": 29 } ], "distribution": [ { "@type": "DataDownload", "contentUrl": "https://tweetindex.com/api/accounts/evidpediatria", "encodingFormat": "application/json" } ], "@id": "https://tweetindex.com/account/evidpediatria#dataset" }

Evid Pediatría

@evidpediatria · España-Spain · joined 09 Mar 2010

Evidencias en Pediatría. Publicación de la Asociación Española de Pediatría y de la Asociación de Pediatría de Atención primaria. #EvidPediatr

24 677Followers

4 599Following

40 748Posts total

3.5KViews on collected posts

Son gönderiler

Evid Pediatría@evidpediatria10 Sep

Corticoides orales en exacerbaciones asmáticas: sin diferencias entre pautas https://t.co/tkSjVfR5hG https://t.co/F6Cw3Xed1f

1.1K views · 13 likes · 10 reposts · 0 replies Open on X →

Evid Pediatría@evidpediatria10 Sep

https://t.co/ogPQbDlcKU https://t.co/npGlRHFeVW

900 views · 10 likes · 12 reposts · 0 replies Open on X →

Evid Pediatría@evidpediatria10 Sep

Ya llega el siguiente número de Evidencias en pediatría. No te lo pierdas ! https://t.co/bFs6HHXvM7 https://t.co/4FFV0jm8vK

651 views · 6 likes · 4 reposts · 0 replies Open on X →

Evid Pediatría@evidpediatria27 Jul

La administración masiva de azitromicina a lactantes en Mali NO reduce la mortalidad. Un hallazgo crucial que desafía estrategias previas. Lee el análisis completo en #EvidenciasEnPediatría. https://t.co/rTS9HgXQH5 https://t.co/zrf36echh3

366 views · 0 likes · 0 reposts · 0 replies Open on X →

Evid Pediatría@evidpediatria27 Jul

¿Fármacos GLP-1 para la obesidad infantil? 📉 Reducen el IMC a corto plazo, pero faltan datos cruciales sobre su seguridad y sostenibilidad a largo plazo. La precaución es clave. Toda la evidencia aquí: https://t.co/VWcV9DWngP https://t.co/j0NmheA8cO

435 views · 0 likes · 0 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 3 gönderi, 10K–100K takipçi aralığıyla yan yana. boyutuna göre olağan erişim, çoğundan daha güçlü tepki.

Medyan görüntülenme900bu hesap92410K–100K için medyan

Erişim, %3.65%bu hesap3.62%10K–100K için medyan

Etkileşim, %2.00%bu hesap1.52%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	900	924	0.97×
Erişim (görüntülenme ÷ takipçi)	3.65%	3.62%	1.01×
Etkileşim oranı	2.00%	1.52%	1.31×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.